Vectors Research Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Vectors Research Management’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50	Closed	-$9K	–	515
2022 Q2	$9K	Hold	50	–	–	﹤0.01%	385
2022 Q1	$7K	Hold	50	–	–	﹤0.01%	395
2021 Q4	$8K	Hold	50	–	–	﹤0.01%	458
2021 Q3	$8K	Hold	50	–	–	﹤0.01%	390
2021 Q2	$8K	Hold	50	–	–	﹤0.01%	413
2021 Q1	$7K	Sell	50 -50	-50%	-$8.06K	﹤0.01%	368
2020 Q4	$18K	Buy	+100	New	+$18.6K	0.01%	285
2020 Q3	–	Sell	-100	Closed	-$16.7K	–	249
2020 Q2	$17K	Hold	100	–	–	0.01%	248
2020 Q1	$12K	Hold	100	–	–	0.01%	284
2019 Q4	$11K	Hold	100	–	–	﹤0.01%	338
2019 Q3	$9K	Hold	100	–	–	﹤0.01%	303
2019 Q2	$7K	Hold	100	–	–	﹤0.01%	302
2019 Q1	$7K	Hold	100	–	–	﹤0.01%	308
2018 Q4	$6K	Buy	+100	New	+$6.27K	﹤0.01%	505

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vectors Research Management's SGEN Position: Q3 2022 in Review

Vectors Research Management sold out of Seagen Inc. Common Stock (SGEN) in Q3 2022, closing a stake of 50 shares — an estimated $9K sold.

Vectors Research Management first reported a position in SGEN in Q4 2018 and held it in 14 quarters. The position peaked at $18K in Q4 2020. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

Vectors Research Management reported no remaining Seagen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 50 Seagen Inc. Common Stock shares in Q3 2022, an estimated $9K.
Vectors Research Management first reported a position in Seagen Inc. Common Stock in Q4 2018 and held it in 14 quarters.
Vectors Research Management's Seagen Inc. Common Stock position peaked at $18K in Q4 2020.
539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.